Navigation Links
Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
Date:5/25/2011

LONDON, May 25, 2011 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that additional positive clinical and preclinical results from its development program of lesinurad, the Company's lead product candidate for the treatment of hyperuricemia and gout, were presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in London, UK.

Results from Primary Dosing Period and Ongoing Extension of Phase 2b Combination Study with Allopurinol

Results presented from the ongoing blinded extension portion of Ardea's Phase 2b study (study 203) of lesinurad in patients who did not achieve target on allopurinol therapy alone demonstrated that for those patients who have reached week 28 of the extension period, 91 percent of those patients receiving lesinurad in combination with allopurinol achieved serum urate (sUA) levels below the clinically important target of 6 mg/dL.  Importantly, continued reductions in sUA were observed beyond the initial 28 days of dosing with a majority of the responding patients remaining on a 200 mg dose of lesinurad thus far in the extension period.  These preliminary results are from the extension portion of a 28-day, randomized, double-blind, placebo-controlled Phase 2b study evaluating lesinurad in combination with allopurinol in 208 gout patients with elevated sUA greater than or equal to 6 mg/dL who were not adequately responding despite being on a stable dose of allopurinol.  Following the 28-day primary dosing period and at least a two-week washout, 126 patients entered the optional extension period and restarted dosing with 200 mg of lesinurad or placebo.  Non-responding patients can be escalated up to 400 mg or 600 mg of lesinurad, at the investigators' discretion.  Currently, 30 patients have been dosed for at least 6 m
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today reported net income for ... $5.09 per diluted share, and non-GAAP net income of $94.0 ... same period a year earlier was $93.3 million, or $0.81 ... or $0.84 per diluted share.  Net sales ...
(Date:7/29/2014)... 29, 2014 New technology in the form ... physicians to see and assess brain tissue more clearly ... study authors who released their findings today at the ... Meeting in Colorado Springs, CO. ... of neurointervention, a specialty that facilitates stroke treatment by ...
(Date:7/29/2014)... -- McGraw-Hill Education Professional, a leading global provider of ... communities, has announced the launch of the AccessMedicine ... world-renowned medical education platform. A key ... for download onto all iOS and Android devices, is ... to valuable AccessMedicine diagnostic resources in an ...
Breaking Medicine Technology:Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3
... Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, ... or "AOBO"), a pharmaceutical company dedicated to improving ... a broad range of prescription and over-the-counter ("OTC") ... Wujia Rongxue Oral Liquid, ("AWRO Liquid"), an OTC ...
... Nov. 11, 2010 Misonix, Inc. (Nasdaq: ... ultrasonic medical device technology, which worldwide is used for ... quarter ended September 30, 2010 financial results on Monday, ... Executive Officer and Richard Zaremba, Senior VP and Chief ...
Cached Medicine Technology:American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid 2Misonix Schedules First Quarter 2011 Financial Results Conference Call; November 15, 2010 at 4:30 P.M. Eastern 2
(Date:7/29/2014)... July 29, 2014 Daily Gossip indicates in ... method was created for any sufferer who is looking for ... The author of the new program, Sarah Summer, says that ... suffered from yeast infection, too. Actually, this is the reason ... this problem. , The Natural Cure for Yeast ...
(Date:7/29/2014)... 29, 2014 Winter is here down ... afternoon in Sydney’s central business district. That is, until ... costume transformed the otherwise ordinary day into a celebration—a ... are ardent advocates of The Truth About Drugs, a ... Scientology . They woke up the city with a ...
(Date:7/29/2014)... Daily Gossip writes in its Fibroids Miracle review ... will teach users how to permanently eliminate uterine fibroids. The ... all over the world. , They have been able ... as quickly as 12 hours. This means that pain and ... , The Fibroids Miracle review also indicates that the method ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Daily Gossip indicates ... some unique tips to gain beautiful and clear skin in ... sufferers will see these positive results even sooner than that. ... Mike Walden, who used this step by step program, too. ... severe acne for years. Mike battled this condition for a ...
(Date:7/29/2014)... 2014 Advertising claims for cosmetic procedures using stem ... for safety and effectiveness, according to a review in ... Surgery , the official medical journal of the ... "Stem cells offer tremendous potential, but the marketplace is ... place patients at risk," write Dr Michael T. Longaker ...
Breaking Medicine News(10 mins):Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2Health News:Sydney Business District “Rocked” by The Truth About Drugs 2Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2Health News:Acne No More Review Reveals Most Effective Acne Cure Program 2Health News:Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery 2
... , , , , ... , , ROSEMONT, Ill., Aug. 3 A new ... of Bone and Joint Surgery (JBJS) finds that two years ... arthodesis (spine fusion) can be expected to have significant improvement in their ...
... , , , ST. LOUIS, ... tools such as Facebook, Twitter and YouTube are being used by ... Now, Anthem Blue Cross and Blue Shield members can add these ... insurer. In an effort to remain engaged and responsive to its ...
... 3 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. ... its Slavica BioChem division have reported results on ... Hyperbaric oxygenation (HBO) after traumatic brain injury have ... with doctors from the Hyperbaric Medical Center, School ...
... ... music by Jack Johnson, Ben Harper, Jason Mraz, G. Love & others , ... Los Angeles, CA (PRWEB) August 3, 2009 -- Domestix, a ... the Malibu Film Festival on Thursday, August 6th at the Malibu Cinemas. "Domestix is thrilled to ...
... Aug. 3 Pharmacy & Healthcare Communications, LLC announces the ... Times , a monthly journal that reaches the universe of ... as its website, www.PharmacyTimes.com , which has ... including Pharmacy Times Careers and ...
... injecting man-made, microscopic tubes into tumors and heating them with ... a way to effectively kill kidney tumors in nearly 80 ... potential future cancer treatment for humans. The study appears ... National Academy of Sciences ). It is the result of ...
Cached Medicine News:Health News:Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches 2Health News:Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches 3Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 2Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 3Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 2Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 3Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 4Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 2Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 3Health News:Pharmacy Times Names New Editorial Director 2Health News:Researchers effectively treat tumors with use of nanotubes 2Health News:Researchers effectively treat tumors with use of nanotubes 3
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 16 mm....
Medicine Products: